Covestor’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Buy |
4,028
+140
| +4% | +$904 | 0.02% | 1145 |
|
|
2025
Q1 | $19K | Buy |
3,888
+942
| +32% | +$4.6K | 0.01% | 1212 |
|
|
2024
Q4 | $28K | Buy |
2,946
+2,893
| +5,458% | +$27.5K | 0.02% | 1059 |
|
|
2024
Q3 | $0 | Sell |
53
-25
| -32% | – | ﹤0.01% | 2326 |
|
|
2024
Q2 | $0 | Buy |
78
+52
| +200% | – | ﹤0.01% | 2341 |
|
|
2024
Q1 | $0 | Sell |
26
-1
| -4% | – | ﹤0.01% | 2343 |
|
|
2023
Q4 | $0 | Buy |
27
+14
| +108% | – | ﹤0.01% | 2256 |
|
|
2023
Q3 | $0 | Buy |
13
+8
| +160% | – | ﹤0.01% | 2234 |
|
|
2023
Q2 | $0 | Sell |
5
-1
| -17% | – | ﹤0.01% | 2239 |
|
|
2023
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 2147 |
|
|
2022
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 2178 |
|
|
2022
Q3 | $0 | Sell |
6
-1,839
| -100% | – | ﹤0.01% | 2121 |
|
|
2022
Q2 | $57K | Buy |
1,845
+233
| +14% | +$7.2K | 0.05% | 685 |
|
|
2022
Q1 | $66K | Buy |
1,612
+491
| +44% | +$20.1K | 0.04% | 699 |
|
|
2021
Q4 | $49K | Buy |
+1,121
| New | +$49K | 0.07% | 551 |
|